A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC

Name: A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC
License: Public Domain

Anbogen Therapeutics, Inc. · clinicaltrials

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

immunotherapy

colorectal cancer (diagnosis), colorectal cancer metastatic, colorectal cancer (crc), immunotherapy

ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Record · ID 121331 · SHA-256 e5bfa50054351e7a
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.